GlassScriptPhysician profile
Amit Toor
NPI 1124568076
$2,875.02
in general payments reported to CMS, 2019-2025
17 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.68 · 2020: $189 · 2021: $678 · 2022: $1,049 · 2023: $320 · 2024: $308 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.89 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $709.55 | 2020-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $353.12 | 2021-2024 | Arexvy |
| Insmed, INC. | $307.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.56 | 2021-2023 | Ofev |
| Actelion Pharmaceuticals US, INC. | $249.36 | 2020-2023 | Uptravi, Opsumit |
| Stryker Corporation | $169.53 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $168.27 | 2019-2020 | |
| Inari Medical, INC. | $166.54 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Genentech, INC. | $145.14 | 2023 | |
| Ethicon INC. | $139.96 | 2022-2023 | Monarch Platform |
| Jazz Pharmaceuticals INC. | $65.70 | 2021-2022 | |
| Edwards Lifesciences Corporation | $31.24 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.64 | 2023 | |
| Electromed, INC. | $20.08 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $19.45 | 2024 | Impella |
| Haemonetics Corporation | $15.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Toor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.